AstraZeneca | العاصمة قرض



Loan Capital تغيير تاريخ
AbbVie USD 60.34B 1.83B 2024-12
Alcon AG USD 4.6B 58M 2025-03
Almirall EUR 390.63M 38.87M 2024-12
Amgen USD 54.01B 2.54B 2025-03
AstraZeneca USD 27.89B 154M 2025-03
Autolus Therapeutics Ltd 253.44M 8.84M 2025-03
Bayer EUR 35.02B 468M 2025-03
Biogen USD 4.55B 1.4M 2024-12
Bristol-Myers Squibb USD 46.16B 1.45B 2025-03
Eli Lilly USD 34.5B 5.97B 2025-03
Fresenius EUR 11.4B 1.88B 2025-03
Fresenius Medical Care EUR 9.51B 253.41M 2025-03
Galapagos EUR 7.79M 453K 2025-03
Genmab DKK 129M 808M 2025-03
Gilead Sciences USD 24.9B 3.46B 2024-12
GlaxoSmithKline GBP 16.47B 1.84B 2025-03
GRIFOLS EUR 9.39B 709.61M 2025-03
Haleon 8.64B 1.14B 2024-12
Hikma Pharmaceutical USD 1.06B 31M 2024-06
Indivior 311M 4M 2025-03
Lonza CHF 4.24B 602M 2024-12
Merck EUR 6.37B 1.51B 2024-12
Merck USD 33.48B 978M 2025-03
Novartis USD 22.93B 2.41B 2024-12
Orion EUR 290.8M 6.4M 2025-03
Pfizer USD 57.64B 234M 2025-03
Philips EUR 7.06B 57M 2025-03
Recordati EUR 2.05B 784.54M 2025-03
Regeneron Pharmaceuticals USD 2.7B 400K 2025-03
Roche Holding CHF 32.1B 1.94B 2024-12
Sanofi 13.41B 1.62B 2025-03
UCB EUR 2.82B 166M 2024-12



AstraZeneca العاصمة قرض - القيم الحالية، والبيانات التاريخية، والتنبؤات والإحصاءات والرسوم البيانية والتقويم الاقتصادي - May 2025.